Modulation of co-stimulatory signal from CD2–CD58 proteins by a grafted peptide

Pravin Parajuli, Rushikesh Sable, Leeza Shrestha, Achyut Dahal, Ted Gauthier, Veena Taneja, Seetharama Jois

Research output: Contribution to journalArticlepeer-review


Peptides were designed to inhibit the protein–protein interaction of CD2 and CD58 to modulate the immune response. This work involved the design and synthesis of eight different peptides by replacing each amino acid residue in peptide 6 with alanine as well as grafting the peptide to the sunflower trypsin-inhibitor framework. From the alanine scanning studies, mutation at position 2 of the peptide was shown to result in increased potency to inhibit cell adhesion interactions. The most potent peptide from the alanine scanning was further studied for its detailed three-dimensional structure and binding to CD58 protein using surface plasmon resonance and flow cytometry. This peptide was used to graft to the sunflower trypsin inhibitor to improve the stability of the peptide. The grafted peptide, SFTI-a1, was further studied for its potency as well as its thermal, chemical, and enzymatic stability. The grafted peptide exhibited improved activity compared to our previously grafted peptide and was stable against thermal and enzymatic degradation.

Original languageEnglish (US)
Pages (from-to)607-627
Number of pages21
JournalChemical Biology and Drug Design
Issue number3
StatePublished - Mar 2021


  • CD2
  • CD58
  • alanine scanning
  • cell adhesion
  • immunomodulation
  • protein–protein interaction

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Modulation of co-stimulatory signal from CD2–CD58 proteins by a grafted peptide'. Together they form a unique fingerprint.

Cite this